Cite
MLA Citation
Samuel Lederman et al.. “Phase 3 Study of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause [A132].” Obstetrics and gynecology, vol. 139, n.d., p. 39S. http://access.bl.uk/ark:/81055/vdc_100156698145.0x000056